152 related articles for article (PubMed ID: 28210808)
1. Change in Oxygen Consumption Following Inhalation of Albuterol in Comparison with Levalbuterol in Healthy Adult Volunteers.
Virk MK; Hotz J; Khemani RG; Newth CJ; Ross PA
Lung; 2017 Apr; 195(2):233-239. PubMed ID: 28210808
[TBL] [Abstract][Full Text] [Related]
2. Increase in oxygen consumption after albuterol inhalation in ventilated infants and children.
Ross PA; Newth CJ; Hugen CA; Maher JK; Deakers TW
Pediatr Crit Care Med; 2014 Nov; 15(9):e389-92. PubMed ID: 25370071
[TBL] [Abstract][Full Text] [Related]
3. Retrospective comparison of nebulized levalbuterol and albuterol for adverse events in patients with acute airflow obstruction.
Scott VL; Frazee LA
Am J Ther; 2003; 10(5):341-7. PubMed ID: 12975718
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of nebulized levalbuterol in stable COPD.
Datta D; Vitale A; Lahiri B; ZuWallack R
Chest; 2003 Sep; 124(3):844-9. PubMed ID: 12970007
[TBL] [Abstract][Full Text] [Related]
5. A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects.
Tripp K; McVicar WK; Nair P; Corren J; Pleskow WW; Goodwin E; Baumgartner RA; Hanrahan JP
J Allergy Clin Immunol; 2008 Sep; 122(3):544-9. PubMed ID: 18692886
[TBL] [Abstract][Full Text] [Related]
6. Effects of nebulized bronchodilator therapy on heart rate and arrhythmias in critically ill adult patients.
Khorfan FM; Smith P; Watt S; Barber KR
Chest; 2011 Dec; 140(6):1466-1472. PubMed ID: 21960699
[TBL] [Abstract][Full Text] [Related]
7. Pairwise comparison of levalbuterol versus racemic albuterol in the treatment of moderate-to-severe asthma.
Pleskow WW; Nelson HS; Schaefer K; Claus R; Roach JM
Allergy Asthma Proc; 2004; 25(6):429-36. PubMed ID: 15709454
[TBL] [Abstract][Full Text] [Related]
8. The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in pediatric patients.
Gawchik SM; Saccar CL; Noonan M; Reasner DS; DeGraw SS
J Allergy Clin Immunol; 1999 Apr; 103(4):615-21. PubMed ID: 10200010
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Inhaled Levalbuterol Compared to Albuterol in Horses with Recurrent Airway Obstruction.
Arroyo MG; Couëtil LL; Nogradi N; Kamarudin MM; Ivester KM
J Vet Intern Med; 2016 Jul; 30(4):1333-7. PubMed ID: 27282625
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of levalbuterol metered dose inhaler in pediatric patients with asthma: a double-blind, randomized, placebo- and active-controlled trial.
Berger WE; Milgrom H; Skoner DP; Tripp K; Parsey MV; Baumgartner RA;
Curr Med Res Opin; 2006 Jun; 22(6):1217-26. PubMed ID: 16846555
[TBL] [Abstract][Full Text] [Related]
11. A comparison of heart rate changes associated with levalbuterol and racemic albuterol in pediatric cardiology patients.
Kelly A; Kennedy A; John BM; Duane B; Lemanowicz J; Little J
Ann Pharmacother; 2013 May; 47(5):644-50. PubMed ID: 23613097
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the dose response to levalbuterol with and without pretreatment with S-albuterol after methacholine-induced bronchoconstriction.
Raissy HH; Harkins M; Esparham A; Kelly HW
Pharmacotherapy; 2007 Sep; 27(9):1231-6. PubMed ID: 17723076
[TBL] [Abstract][Full Text] [Related]
13. Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma.
Nelson HS; Bensch G; Pleskow WW; DiSantostefano R; DeGraw S; Reasner DS; Rollins TE; Rubin PD
J Allergy Clin Immunol; 1998 Dec; 102(6 Pt 1):943-52. PubMed ID: 9847435
[TBL] [Abstract][Full Text] [Related]
14. Levalbuterol is as effective as racemic albuterol in lowering serum potassium.
Pancu D; LaFlamme M; Evans E; Reed J
J Emerg Med; 2003 Jul; 25(1):13-6. PubMed ID: 12865102
[TBL] [Abstract][Full Text] [Related]
15. Chronic inhalation of nebulized levalbuterol does not increase mucociliary clearance in healthy subjects.
Cleary JC; Karmazyn Y; Mogayzel PJ; Laube BL
Pulm Pharmacol Ther; 2008; 21(1):105-11. PubMed ID: 17360209
[TBL] [Abstract][Full Text] [Related]
16. Comparison of levalbuterol and racemic albuterol based on cardiac adverse effects in children.
Bio LL; Willey VJ; Poon CY
J Pediatr Pharmacol Ther; 2011 Jul; 16(3):191-8. PubMed ID: 22479161
[TBL] [Abstract][Full Text] [Related]
17. Levalbuterol: pharmacologic properties and use in the treatment of pediatric and adult asthma.
Berger WE
Ann Allergy Asthma Immunol; 2003 Jun; 90(6):583-91; quiz 591-2, 659. PubMed ID: 12839314
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience with levalbuterol.
Nelson HS
J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 2):S77-84. PubMed ID: 10452792
[TBL] [Abstract][Full Text] [Related]
19. Changes in heart rate associated with nebulized racemic albuterol and levalbuterol in intensive care patients.
Lam S; Chen J
Am J Health Syst Pharm; 2003 Oct; 60(19):1971-5. PubMed ID: 14531242
[TBL] [Abstract][Full Text] [Related]
20. Levalbuterol inhibits human airway smooth muscle cell proliferation: therapeutic implications in the management of asthma.
Ibe BO; Portugal AM; Raj JU
Int Arch Allergy Immunol; 2006; 139(3):225-36. PubMed ID: 16446544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
